• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Grove's Programmatic Ad Tech Platform, Interactive Offers, Signs on 4 Major Partners

    7/7/22 8:30:00 AM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $GRVI alert in real time by email

    HENDERSON, NV, July 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Grove Inc. (GRVI) announced that its wholly owned Adtech platform, Interactive Offers, continues its expansion into eCommerce with the addition of new partners within the financial industry to further boost its growing list of advertisers and publishers using its SaaS advertising platform.

    The company has now partnered with Outbrain, ZeroHedge, StreetAuthority, and InvestingDaily, who will now utilize Interactive's SaaS advertising technology to monetize their current database as well as bring in new, targeted leads/customers.

    Interactive Offers continues to establish its relationship with some of the biggest publishers and advertisers in the finance industry, as well as eCommerce giants, like its recent partnership with Maropost.

    The reality is that advertising online has become more expensive, month after month. Cost-per-click across mainstream channels like Facebook, Instagram, Google, and YouTube, has increased to a level that is nearly unattainable for most businesses to scale. Even worse, the traffic quality is diminishing, and verifiable clicks are dwindling.

    Interactive Offers provides a comprehensive programmatic ad tech solution. IO verifies clicks are authentic, while operating for publishers and advertisers on a performance benchmark and acquiring leads/customers instead of charging per click or by impression. The company continues to expand as businesses look for reliable traffic to their products/services.

    The company is rapidly scaling its click-to-opt-in program that can be used in email advertising, display advertising, and even on transactional confirmation pages. This helps deliver an even higher quality of customers with catered ads based on the user's buying behavior.

    For eCommerce brands, especially, with the use of third-party cookies being disabled across the web, the ability to retarget consumers isn't what it used to be. Interactive Offers can now provide a way for advertisers to speak directly to customers through first party data who have just recently bought a product/service, and give them an instant, complimentary offer, based on their buying history. This will increase the cart value for publishers and provide advertisers with highly targeted customers with the click of a button.

    About Grove, Inc.

    Grove, Inc. is a global innovator in hemp, health and wellness. The company has an array of in-house brands and operates in multiple verticals including SaaS programmatic ad technology, and a wholly owned division dedicated to acquiring high growth e-commerce brands. The company sells to numerous consumer markets including the botanical, beauty, pet care, and functional foods sectors. It seeks to take advantage of an emerging worldwide trend in consumer products selling through Amazon and E-commerce.

    Company Contact

    Andrew Norstrud

    Email: [email protected]

    Phone: (702) 332-5591

    Investor Relations Contact

    TraDigital IR

    John McNamara

    Email: [email protected]

    Phone: (917) 658-2602

    Forward-Looking Statements

    This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with business strategy, potential acquisitions, revenue guidance, product development, integration and synergies of acquiring companies and personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K and other periodic reports filed from time-to-time with the Securities and Exchange Commission.



    Primary Logo

    Get the next $GRVI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GRVI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GRVI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Grove, Inc. Announces Name and Symbol Change to Upexi, Inc. "UPXI"

    HENDERSON, Nev., Aug. 17, 2022 /PRNewswire/ -- Grove Inc. (NASDAQ:GRVI), a market leader in Amazon and eCommerce brand ownership and aggregation, announces that today, August 17, 2022, its trading name on the Nasdaq officially changed from "Grove Inc." to "Upexi, Inc." and its ticker symbol changed from "GRVI" to "UPXI". This accompanies previous press releases notifying investors of this change. CEO Allan Marshall stated, "Last month, we announced our growth strategy in a letter to shareholders that focused on our acquisition plan to bring more, profitable eCommerce brands in various industries under our umbrella. Moving to a new name and stock ticker is a reflection of the progress we have

    8/17/22 4:05:00 PM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sidoti's August Micro-Cap Virtual Conference

    Presentation Times and Weblinks Released for Over 50 Presenting CompaniesWednesday and Thursday, August 17-18, 2022NEW YORK, NY / ACCESSWIRE / August 16, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 17-18, 2022. The links can also be found at www.sidoticonference.com/events.Presentation AgendaWednesday, August 17th, 2022 (Day 1)*All Times EDT8:30-9:00Mativ Holdings, Inc. (MATV)Brenmiller Energy, Ltd. (BNRG)Sify Technologies Ltd (SIFY)9:15-9:45MISTRAS Group (MG)Bassett Furniture (BSET)Silvercrest Asset Management Group (SAMG)10:00-10:30Anebulo Pharmaceuticals (ANEB)*****

    8/16/22 3:00:00 PM ET
    $AIRI
    $ANEB
    $APRN
    Military/Government/Technical
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Update: Grove, Inc. to Present at Sidoti August Microcap Conference

    HENDERSON, NV , Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Grove Inc. (GRVI) announced today that Allan Marshall, Chief Executive Officer, is scheduled to present virtually at the Sidoti & Company, August Virtual Microcap Conference on Wednesday, August 17, 2022 at 3:15 pm ET. The presentation can be accessed live at: https://sidoti.zoom.us/webinar/register/WN_FqCzxA3xTbOsMXr-Ml5X7Q Grove will also host virtual one-on-ones with investors throughout the conference.  To register for the presentation of a one-on-one meeting, visit https://www.sidoti.com/events/august-micro-cap-virtual-conference. Registration is free and you are not required to be a Sidoti & Company client. 

    8/10/22 10:56:39 AM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GRVI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Marshall Allan bought $63,909 worth of shares (17,303 units at $3.69), increasing direct ownership by 0.68% to 2,575,081 units

    4 - UPEXI, INC. (0001775194) (Issuer)

    1/11/23 4:56:21 PM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4: Marshall Allan bought $49,320 worth of shares (12,000 units at $4.11), increasing direct ownership by 0.47% to 2,557,778 units

    4 - UPEXI, INC. (0001775194) (Issuer)

    12/13/22 5:48:52 PM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4: Marshall Allan bought $73,161 worth of shares (18,475 units at $3.96), increasing direct ownership by 0.73% to 2,545,778 units

    4 - UPEXI, INC. (0001775194) (Issuer)

    12/5/22 3:24:06 PM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GRVI
    SEC Filings

    View All

    Grove Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - UPEXI, INC. (0001775194) (Filer)

    12/15/22 4:05:24 PM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by Grove Inc.

    EFFECT - UPEXI, INC. (0001775194) (Filer)

    12/5/22 12:15:12 AM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Grove Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - UPEXI, INC. (0001775194) (Filer)

    12/2/22 9:15:45 AM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GRVI
    Financials

    Live finance-specific insights

    View All

    Grove, Inc. Announces Fiscal Year 2021 Audited Financial Results

    Revenues Reach $24.1 Million, a 250% Increase Over 2020 Net Earnings of $2.9 Million or $.25 Per Share HENDERSON, NV, Sept. 29, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Grove, Inc. (NASDAQ:GRVI) ("Grove" or the "Company"), a global innovator in hemp, health, and wellness, today announced audited financial results for its fiscal year ended June 30, 2021 which surpassed preliminary results issued on June 28, 2021.   Investors are encouraged to read the Company's annual report on Form 10-K which was filed with the Securities and Exchange Commission (the "SEC"), contains additional information, and is posted at https://groveinc.io/ Financial Highlights $2

    9/29/21 8:00:00 AM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $GRVI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Grove Inc.

    SC 13G - GROVE, INC. (0001775194) (Subject)

    2/14/22 4:08:22 PM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Grove Inc.

    SC 13G - GROVE, INC. (0001775194) (Subject)

    2/14/22 4:07:48 PM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Grove Inc.

    SC 13G - GROVE, INC. (0001775194) (Subject)

    2/14/22 4:07:14 PM ET
    $GRVI
    Biotechnology: Pharmaceutical Preparations
    Health Care